GR3035287T3 - Insulin and amylin containing composition for the treatment of insulin deficient mammals. - Google Patents
Insulin and amylin containing composition for the treatment of insulin deficient mammals.Info
- Publication number
- GR3035287T3 GR3035287T3 GR20010400101T GR20010400101T GR3035287T3 GR 3035287 T3 GR3035287 T3 GR 3035287T3 GR 20010400101 T GR20010400101 T GR 20010400101T GR 20010400101 T GR20010400101 T GR 20010400101T GR 3035287 T3 GR3035287 T3 GR 3035287T3
- Authority
- GR
- Greece
- Prior art keywords
- insulin
- amylin
- treatment
- containing composition
- deficient mammals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70499591A | 1991-05-24 | 1991-05-24 | |
PCT/US1992/004351 WO1992020366A1 (en) | 1991-05-24 | 1992-05-23 | Insulin and amylin containing composition for the treatment of insulin deficient mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3035287T3 true GR3035287T3 (en) | 2001-04-30 |
Family
ID=24831674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20010400101T GR3035287T3 (en) | 1991-05-24 | 2001-01-24 | Insulin and amylin containing composition for the treatment of insulin deficient mammals. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0586592B1 (el) |
JP (1) | JPH06510753A (el) |
AT (1) | ATE197764T1 (el) |
AU (2) | AU2169392A (el) |
CA (1) | CA2109604A1 (el) |
DE (1) | DE69231583T2 (el) |
DK (1) | DK0586592T3 (el) |
ES (1) | ES2153828T3 (el) |
GR (1) | GR3035287T3 (el) |
SG (1) | SG44838A1 (el) |
WO (1) | WO1992020366A1 (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0586589T3 (da) * | 1991-05-24 | 1997-09-22 | Amylin Pharmaceuticals Inc | Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande |
EP1196189A2 (en) | 1999-06-25 | 2002-04-17 | Medtronic MiniMed, Inc. | Multiple agent diabetes therapy |
AU2002248464A1 (en) | 2001-02-21 | 2002-09-12 | Medtronic Minimed, Inc. | Stabilized insulin formulations |
US6737401B2 (en) | 2001-06-28 | 2004-05-18 | Metronic Minimed, Inc. | Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
GB8915712D0 (en) * | 1989-07-08 | 1989-08-31 | Macintyre Iain | Medical treatment |
-
1992
- 1992-05-23 CA CA002109604A patent/CA2109604A1/en not_active Abandoned
- 1992-05-23 WO PCT/US1992/004351 patent/WO1992020366A1/en active IP Right Grant
- 1992-05-23 SG SG1996008450A patent/SG44838A1/en unknown
- 1992-05-23 AT AT92913644T patent/ATE197764T1/de active
- 1992-05-23 DE DE69231583T patent/DE69231583T2/de not_active Expired - Lifetime
- 1992-05-23 ES ES92913644T patent/ES2153828T3/es not_active Expired - Lifetime
- 1992-05-23 DK DK92913644T patent/DK0586592T3/da active
- 1992-05-23 EP EP92913644A patent/EP0586592B1/en not_active Expired - Lifetime
- 1992-05-23 AU AU21693/92A patent/AU2169392A/en not_active Abandoned
- 1992-05-23 JP JP5500328A patent/JPH06510753A/ja active Pending
-
1996
- 1996-08-07 AU AU61964/96A patent/AU6196496A/en not_active Abandoned
-
2001
- 2001-01-24 GR GR20010400101T patent/GR3035287T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2169392A (en) | 1992-12-30 |
JPH06510753A (ja) | 1994-12-01 |
AU6196496A (en) | 1996-10-10 |
DE69231583D1 (de) | 2001-01-04 |
CA2109604A1 (en) | 1992-11-26 |
ES2153828T3 (es) | 2001-03-16 |
EP0586592B1 (en) | 2000-11-29 |
DE69231583T2 (de) | 2001-03-29 |
DK0586592T3 (da) | 2000-12-27 |
ATE197764T1 (de) | 2000-12-15 |
EP0586592A1 (en) | 1994-03-16 |
SG44838A1 (en) | 1997-12-19 |
WO1992020366A1 (en) | 1992-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3001151T3 (en) | Dressing for the treatment of wounds and manufacturing process | |
GEP19981274B (en) | Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition | |
KR960014776B1 (en) | Composition for stimulating hair growth | |
IL98258A0 (en) | Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046 | |
GR3007092T3 (el) | ||
ZA858105B (en) | A pharmaceutical composition and a method of treating the body | |
LTIP1582A (en) | Compositions of medicinal preparation and hyaluronic acid for treatment of conditions and disease | |
KR880010764A (ko) | 과콜레스테롤혈중 치료용 혼합물 | |
IN166787B (el) | ||
GB9517443D0 (en) | Increasing creatine and glycogen concentration in muscle | |
ES2010561A6 (es) | Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina. | |
GR1002802B (el) | Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος | |
GR3031129T3 (en) | Enhancement of glutathione levels with glutamine | |
EP0981360A4 (en) | METHOD FOR PREVENTING GASTRITIS USED BY AMYLIN OR AMYLIN AGONISTS | |
GR860900B (en) | Amino-propanol derivatives method for their preparation their use and medicaments containing them | |
IL103383A0 (en) | Pharmaceutical compositions containing glutamine and methods for the use thereof | |
NO885023D0 (no) | Fremgangsmte for reduksjon av nitrogenoxydinnholdet i en avlsstr under anvendelse av sukker. | |
SG44838A1 (en) | Insulin and amylin containing composition for the treatment of insulin deficient mammals | |
KR880012235A (ko) | 정상 포유동물의 헤마토크릿을 증가시키는 방법 | |
IL86928A (en) | Castanospermine esters and glycosides,their preparation and compositions containing them for treating diabetes and postprandial hyperglycemia | |
EP0285441A3 (en) | Synergistic immunostimulating composition and method | |
GR1002317B (el) | Προαγωγη της αναπτυξεως χοιρων. | |
CA2010054A1 (en) | Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin | |
TJ286B (en) | A method for treatment or prevention of obesity | |
EP0308717A3 (en) | Method of treating viral encephalitis |